We are live on ! Find out more
MU

Mirova US Portfolio holdings

AUM $8.81B
1-Year Est. Return 21.38%
This Fund
S&P 500
This Quarter Est. Return
-6.92%
1 Year Est. Return
+21.38%
3 Year Est. Return
+80.7%
5 Year Est. Return
+106.85%
10 Year Est. Return
AUM
$4.28B
AUM Growth
-$363M
Cap. Flow
+$28.7M
Cap. Flow %
0.67%
Top 10 Hldgs %
62.29%
Holding
30
New
2
Increased
Reduced
27
Closed
1

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$75.4M
2
DE icon
Deere & Co
DE
+$73.7M

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$87.7M
2
TSM icon
TSMC
TSM
+$4.33M
3
TMO icon
Thermo Fisher Scientific
TMO
+$3.32M
4
MELI icon
Mercado Libre
MELI
+$3.31M
5
RUN icon
Sunrun
RUN
+$3.18M

Sector Composition

Rank Sector Weight
1 Technology 25.75%
2 Healthcare 22.82%
3 Financials 16.06%
4 Consumer Discretionary 11.79%
5 Utilities 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BFAM icon
26
Bright Horizons
BFAM
$4.03B
$39.5M 0.92%
684,806
-2,995
-0.4% -$228K
SIVB
27
DELISTED
SVB Financial Group
SIVB
$27.4M 0.64%
81,526
-403
-0.5% -$162K
FSLR icon
28
First Solar
FSLR
$22.8B
$5.77M 0.13%
43,650
-141
-0.3% -$15.1K
WM icon
29
Waste Management
WM
$96.1B
$514K 0.01%
3,214
-514
-14% -$84.8K
CL icon
30
Colgate-Palmolive
CL
$74.4B
-2,592
Closed -$207K

Similar funds

Mirova US's Q3 2022 Portfolio in Review

As of Q3 2022, Mirova US held 30 positions worth $4.28B, down 7.8% from $4.64B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Mirova US's Q3 2022 filing shows 2 new, 27 reduced and 1 closed positions. Its largest new stake was Edwards Lifesciences: 783,459 shares worth $64.7M. The largest sale was Danaher, an estimated $87.7M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • Mirova US's largest Q3 2022 buy was Edwards Lifesciences: 783,459 shares worth $64.7M.
  • Mirova US's biggest Q3 2022 reduction was Danaher, cutting an estimated $87.7M.
  • Mirova US fully exited Colgate-Palmolive in Q3 2022, selling an estimated $207K.
  • Mirova US's ten largest holdings make up 62% of its $4.28B portfolio in Q3 2022.
  • Mirova US opened 2 new positions and closed 1 in Q3 2022.
  • Mirova US's portfolio value fell 7.8% quarter-over-quarter to $4.28B.

Based on Mirova US's 13F filing for Q3 2022, filed 3 Nov 2022.